1. Home
  2. PRTC vs JFIN Comparison

PRTC vs JFIN Comparison

Compare PRTC & JFIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • JFIN
  • Stock Information
  • Founded
  • PRTC 2015
  • JFIN 2011
  • Country
  • PRTC United States
  • JFIN China
  • Employees
  • PRTC N/A
  • JFIN N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • JFIN Finance: Consumer Services
  • Sector
  • PRTC Health Care
  • JFIN Finance
  • Exchange
  • PRTC Nasdaq
  • JFIN Nasdaq
  • Market Cap
  • PRTC 457.3M
  • JFIN 408.4M
  • IPO Year
  • PRTC N/A
  • JFIN 2019
  • Fundamental
  • Price
  • PRTC $18.47
  • JFIN $9.94
  • Analyst Decision
  • PRTC Buy
  • JFIN
  • Analyst Count
  • PRTC 1
  • JFIN 0
  • Target Price
  • PRTC $45.00
  • JFIN N/A
  • AVG Volume (30 Days)
  • PRTC 2.0K
  • JFIN 114.7K
  • Earning Date
  • PRTC 08-28-2024
  • JFIN 03-27-2025
  • Dividend Yield
  • PRTC N/A
  • JFIN 8.84%
  • EPS Growth
  • PRTC N/A
  • JFIN N/A
  • EPS
  • PRTC N/A
  • JFIN 3.08
  • Revenue
  • PRTC $468,000.00
  • JFIN $854,955,021.00
  • Revenue This Year
  • PRTC N/A
  • JFIN N/A
  • Revenue Next Year
  • PRTC $160.00
  • JFIN N/A
  • P/E Ratio
  • PRTC N/A
  • JFIN $3.37
  • Revenue Growth
  • PRTC N/A
  • JFIN 21.87
  • 52 Week Low
  • PRTC $17.00
  • JFIN $4.00
  • 52 Week High
  • PRTC $34.00
  • JFIN $10.56
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 46.10
  • JFIN 62.62
  • Support Level
  • PRTC $18.35
  • JFIN $9.55
  • Resistance Level
  • PRTC $18.89
  • JFIN $10.50
  • Average True Range (ATR)
  • PRTC 0.43
  • JFIN 0.74
  • MACD
  • PRTC 0.00
  • JFIN 0.08
  • Stochastic Oscillator
  • PRTC 26.62
  • JFIN 78.55

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About JFIN Jiayin Group Inc.

Jiayin Group Inc is China's technology service group. It is an enterprise engaged in technological innovation services. It is committed to using big data, cloud computing, artificial intelligence and other technologies to connect consumers and financial institutions in consumption scenarios so that every user can enjoy efficient and convenient technology services. The company has engraved technological innovation into the company's development genes since its establishment, adheres to the dual drive of digital + technology, and focuses on building a cloud service platform and intelligent risk control system with big data drive as the core concept.

Share on Social Networks: